2007
DOI: 10.1016/j.urology.2006.10.016
|View full text |Cite
|
Sign up to set email alerts
|

Lack of Progress in Early Diagnosis of Bladder Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 28 publications
0
14
0
Order By: Relevance
“…the proportion of people without disease who have a negative result) of >90% (Saad et al, 2002;Simon, et al, 2003), it has some important limitations: it has inadequate sensitivity, particularly in well or moderately differentiated tumours (McDonald et al, 2006). Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive. Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive.…”
Section: Urine Cytologymentioning
confidence: 99%
See 1 more Smart Citation
“…the proportion of people without disease who have a negative result) of >90% (Saad et al, 2002;Simon, et al, 2003), it has some important limitations: it has inadequate sensitivity, particularly in well or moderately differentiated tumours (McDonald et al, 2006). Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive. Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive.…”
Section: Urine Cytologymentioning
confidence: 99%
“…Additionally, high rates of atypia are reported in patients with benign pathologies such as those with inflammation, stones or indwelling catheters; there is dependence on experienced cytopathologists and the results can be subjective (Grossman et al, 2005). Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive. Additionally, it takes around a week before the results are available and, therefore, delays diagnosis.…”
Section: Urine Cytologymentioning
confidence: 99%
“…1 However, these techniques are costly and time consuming for both hospitals and patients. In addition, most of these diagnostic tools require the expertise of a cytopathologist, radiologist (e.g., intravenous urography, computed tomography and magnetic resonance urography), or urologist (e.g., cystoscopy).…”
Section: Introductionmentioning
confidence: 99%
“…This approach is the underlying reason for a "lack of progress" in the early diagnosis of bladder cancer. 1 A delay in the detection of invasive bladder cancer increases the risk of bladder cancer death. 2 Therefore, it is crucial to develop an inexpensive, noninvasive, highly sensitive, rapid, and easily automated technique to diagnose bladder cancer in its early stages.…”
Section: Introductionmentioning
confidence: 99%
“…This could have several explanations, among them the exclusion of ‘good‐risk’ patients receiving intravesical therapy and never needing cystectomy. Another study compared stage and survival in two consecutive cystectomy groups operated between 1992 and 2005 at one hospital, finding no improvement in either variable [2].…”
Section: Introductionmentioning
confidence: 99%